KR890700347A - 인터루킨-i활성의 억제 방법 - Google Patents

인터루킨-i활성의 억제 방법

Info

Publication number
KR890700347A
KR890700347A KR1019880701056A KR880701056A KR890700347A KR 890700347 A KR890700347 A KR 890700347A KR 1019880701056 A KR1019880701056 A KR 1019880701056A KR 880701056 A KR880701056 A KR 880701056A KR 890700347 A KR890700347 A KR 890700347A
Authority
KR
South Korea
Prior art keywords
activity
inhibiting interleukin
interleukin
inhibiting
alleviation
Prior art date
Application number
KR1019880701056A
Other languages
English (en)
Other versions
KR960015726B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR890700347A publication Critical patent/KR890700347A/ko
Application granted granted Critical
Publication of KR960015726B1 publication Critical patent/KR960015726B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019880701056A 1986-12-31 1987-12-28 인터루킨-ⅰ활성의 억제방법 KR960015726B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94790586A 1986-12-31 1986-12-31
US947,905 1986-12-31
PCT/US1987/003479 WO1988004928A1 (en) 1986-12-31 1987-12-28 Method of inhibiting interleukin-1 activity

Publications (2)

Publication Number Publication Date
KR890700347A true KR890700347A (ko) 1989-04-24
KR960015726B1 KR960015726B1 (ko) 1996-11-20

Family

ID=25486973

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880701056A KR960015726B1 (ko) 1986-12-31 1987-12-28 인터루킨-ⅰ활성의 억제방법

Country Status (14)

Country Link
EP (1) EP0279079B1 (ko)
JP (1) JP2507012B2 (ko)
KR (1) KR960015726B1 (ko)
AT (1) ATE151290T1 (ko)
AU (1) AU668982B2 (ko)
CA (1) CA1313137C (ko)
DE (1) DE3752048T2 (ko)
DK (1) DK482088A (ko)
ES (1) ES2103255T3 (ko)
GR (1) GR3024054T3 (ko)
IE (1) IE873554L (ko)
IL (7) IL100536A (ko)
WO (1) WO1988004928A1 (ko)
ZA (1) ZA879754B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
JPH04506215A (ja) * 1989-06-13 1992-10-29 スミスクライン・ビーチャム・コーポレイション モノカイン活性干渉
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
EP0493682A3 (en) * 1990-11-30 1992-11-19 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
EP0490181A1 (en) * 1990-11-30 1992-06-17 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for preparation of a medicament having immunosuppressing activity
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
WO1992021344A2 (en) * 1991-05-24 1992-12-10 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
JPH05194233A (ja) * 1991-06-10 1993-08-03 Hoechst Roussel Pharmaceut Inc マイクロペレットおよびそれらの製造方法
WO1993003728A1 (en) * 1991-08-27 1993-03-04 Temple University Of The Commonwealth System Of Xanthine suppression of antigen activation of t- or b-cells
ES2173871T3 (es) * 1991-10-31 2002-11-01 Univ Manchester Tratamiento de condiciones neurologicas por un compuesto inhibidor de la interleukina-1.
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
JP3830115B2 (ja) * 1997-10-06 2006-10-04 シャープ株式会社 液晶表示素子
TW561297B (en) * 1997-11-25 2003-11-11 Toshiba Corp Electrode wiring board subjected to counter measure against static electricity and display device using the same
JP3019053B2 (ja) * 1997-12-25 2000-03-13 日本電気株式会社 液晶表示装置及びその製造方法
BRPI0908107A2 (pt) 2008-02-29 2019-09-24 Concert Pharmaceuticals Inc composto derivado de xantina substituída, composição farmacêutica que compreende esse composto, métodos de tratamento de uma enfermidade ou condição em um paciente com necessidade do mesmo, método de tratamento de enfermidade crônica dos rins, do fígado, relacionada com diabetes e de claudicação intermitente
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CA2771331A1 (en) 2009-09-02 2011-03-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2012031138A2 (en) 2010-09-01 2012-03-08 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2013155465A1 (en) 2012-04-13 2013-10-17 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment

Also Published As

Publication number Publication date
AU4602793A (en) 1993-11-18
EP0279079A2 (en) 1988-08-24
ATE151290T1 (de) 1997-04-15
GR3024054T3 (en) 1997-10-31
DE3752048T2 (de) 1997-10-02
IE873554L (en) 1988-06-30
DK482088D0 (da) 1988-08-30
DK482088A (da) 1988-10-28
JPH02501829A (ja) 1990-06-21
IL100533A (en) 1994-05-30
JP2507012B2 (ja) 1996-06-12
DE3752048D1 (de) 1997-05-15
CA1313137C (en) 1993-01-26
AU668982B2 (en) 1996-05-23
IL100535A (en) 1994-05-30
EP0279079A3 (en) 1990-06-13
AU637542B2 (en) 1993-05-27
WO1988004928A1 (en) 1988-07-14
ES2103255T3 (es) 1997-09-16
IL106859A (en) 1996-10-16
EP0279079B1 (en) 1997-04-09
IL106861A (en) 1997-02-18
AU1150588A (en) 1988-07-27
IL106854A (en) 1996-05-14
AU619732B2 (en) 1992-02-06
IL100536A (en) 1994-05-30
AU1291892A (en) 1992-05-14
IL84934A (en) 1994-08-26
KR960015726B1 (ko) 1996-11-20
ZA879754B (en) 1989-07-26

Similar Documents

Publication Publication Date Title
KR890700347A (ko) 인터루킨-i활성의 억제 방법
IT1177344B (it) Impianto per la produzione automatica di lenti organiche
TR23030A (tr) Asillendirilmis diketonik bilesiklerin ueretilmesine mahsus usul
IT8320709A0 (it) Composto per il trattamento della psoriasi.
DE3855956T2 (de) Verwendung einer Triglyceridverbindung als Hämolysishemmer
IT1194756B (it) Assieme di valvola di ritegno perfezionata
DK377687D0 (da) Triazol-fungicidpraeparater
IT8419329A1 (it) Pomata oleosa avente un'eccellente attività anti-infiammatoria
DK165591C (da) Flerumaettede fluorsubstituerede alkoholforbindelser
FI863525A (fi) Anordning foer foerskjutning och positionering av en kopplad kedjedel i en dragkedja under kompletteringsarbeten.
IT8967178A0 (it) Mandrino agganciabile per il con trollo di pozzi
IT8848523A0 (it) Procedimento integrato per la fitodepurazione di acque reflue
DE3776613D1 (de) Dopamin-beta-hydroxylase-inhibitoren.
ES536258A0 (es) Procedimiento para la obtencion de un aditivo para la conservacion de cefalopodos
IT8148624A0 (it) Procedimento per la purificazione di 2-mercaptobenzotiazolo
SE8605561D0 (sv) Skrepsil for takavvattningsutlopp
LT2310B (lt) Medziagos su reguliuojamu aktyviojo junginio islaisvinimu gavimo budas
IT8334956V0 (it) Attrezzo per la posatura dei giardini delle scale, anche con alzata superiormente inclinata all'indietro
IT8531622V0 (it) Valvola indicastop trafilamento olio
IT207870Z2 (it) Dado di tipo perfezionato
IT8622389A0 (it) Procedimento per la preparazione di composti ad attivita' anti ulcera
BR6500265U (pt) Furadeira hidraulica automatica
KR880001058U (ko) 가습기의 앙금 방지 장치
KR870010429U (ko) 표층수 취수용 사이펀
LV5359A3 (lv) Panemiens nevelamu augu apkarosanai

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee